Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | LVTX |
---|---|---|
09:32 ET | 659 | 2.1 |
09:39 ET | 500 | 2.1112 |
09:48 ET | 2043 | 2.11 |
09:59 ET | 1100 | 2.11 |
10:12 ET | 200 | 2.0615 |
10:33 ET | 714 | 2.108 |
11:58 ET | 1365 | 2.0805 |
12:27 ET | 936 | 2.0943 |
12:34 ET | 656 | 2.095 |
12:41 ET | 800 | 2.07 |
12:50 ET | 1430 | 2.103 |
01:12 ET | 960 | 2.095 |
01:39 ET | 100 | 2.11 |
02:00 ET | 2000 | 2.0894 |
02:26 ET | 321 | 2.11 |
02:42 ET | 4032 | 2.11 |
03:48 ET | 200 | 2.11 |
03:50 ET | 100 | 2.1 |
03:56 ET | 322 | 2.11 |
03:57 ET | 100 | 2.11 |
03:59 ET | 1745 | 2.07 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
LAVA Therapeutics NV | 55.5M | -1.9x | --- |
Kezar Life Sciences Inc | 47.9M | -0.5x | --- |
DURECT Corp | 51.2M | -1.9x | --- |
Atara Biotherapeutics Inc | 47.9M | -0.2x | --- |
BioLine RX Ltd | 62.4M | -1.1x | --- |
Kronos Bio Inc | 80.5M | -0.7x | --- |
LAVA Therapeutics NV, formerly known as Lava Therapeutics BV, is a provider of biotechnology research and development services based in the Netherlands. The Company focuses of developing next generation Vdelta T cell engaging bispecific antibodies to fight cancer.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $55.5M |
---|---|
Revenue (TTM) | $12.5M |
Shares Outstanding | 26.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.50 |
EPS | $-1.07 |
Book Value | $1.95 |
P/E Ratio | -1.9x |
Price/Sales (TTM) | 4.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -252.58% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.